/Investor DB

Polaris Partners — 2024 Investments

7 investments dated 2024 · listed companies and verified rows first · show all

Epi Biologicsepibiologics.cominSeries A · Apr 2024 · $73M

Epibiologics develops protein degradation medicines using protein sciences and antibody engineering capabilities.

BiotechMedical DevicesSan Mateo, US

Ann Lee-Karlon(Executive Officer, Director)inMitchell Mutz(Executive Officer, Director)James Wells(Director)

BoardSamuel Bjork(Director)inSeiji Miyahara(Director)in

Board seatAlexandra Cantley· per SEC Form D

Co-investorsAvego BioScience CapitalGV (Google Ventures)Mission BiocapitalNovartis Venture FundRoche Venture FundSamsara BioCapital+4 more

Noetiknoetik.aiin𝕏Series A · Aug 2024 · $40M

Noetik builds AI models to identify cancer patients most likely to respond to treatments and to discover new oncology drug targets.

AI & Machine LearningBiotechHealthtechSouth San Francisco, US

Jacob Rinaldi(Founder)inRonald Alfa(Executive Officer, Director, Promoter)Ron Alfa, MD, PhD(Co-Founder, CEO)inRon Alfa(Founder)Ron Alfa Jacob Rinaldi(Founder)

BoardJames Hardiman(Director)in

Board seatAmy Schulman· per SEC Form D

Co-investors11.2 CapitalBreakout LabsBreakout VenturesCatalio Capital Management, LPEPIC VENTURESIntermountain Health+6 more

Seismic Therapeuticseismictx.comin𝕏Series A · Sep 2024 · $100M

Seismic Therapeutic is a clinical-stage biotechnology company that uses machine learning to discover and develop immunology therapies for autoimmune diseases.

AI & Machine LearningBiotechDeep TechMedical DevicesBoston, US

Timothy A. Springer(Scientific Advisor / Founder)Jo Viney, PhD(Founder, President and Chief Executive Officer)Alan Crane(Founder and Chairman of Seismic Therapeutic; Polaris Partners)inTim Springer, PhD(Founder of Seismic Therapeutic; Harvard Medical School and Boston Children's Hospital)Debora Marks, PhD(Founder)Andrew Kruse, PhD(Founder)

Board seatAlan Crane· per SEC Form D

Co-investorsBessemer Venture PartnersGaingelsGV (Google Ventures)Lightspeed Venture PartnersMana Ventures

SunBird Biosunbirdbio.comOct 2024 · $14M

Biotechnology company developing blood-based diagnostic tests for neurological disorders and early-stage cancer.

Cambridge, US

Board seatAlexandra Cantley· per SEC Form D

Co-investorsAlumni VenturesARCH Venture PartnersClavystBioS32

Baxter Planningbaxterplanning.cominMay 2024

Baxter Planning provides software and services for service supply chain management, serving enterprises managing complex operational logistics and supplier networks.

AI & Machine LearningEnterprise SoftwareLogistics & Supply ChainSaaS

Anton Chilton(Chief Executive Officer)in

Co-investorsGolub GrowthMarlin Equity Partners

Matter Neurosciencematter.xyzinSeed · Feb 2024 · $26M

Matter develops a consumer iOS app that helps users track positive emotions and brain activity to improve subjective well-being.

AI & Machine LearningConsumerHealthtechMental HealthWellness & Fitness

Axel Bouchon(Founder)inBen Goldhirsh(Co-founder)inChris Shiflett(Co-founder)in

Co-investorsARCH Venture PartnersCollaborative FundExor Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

TRex Holdings Inc.

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.